Bank of Stockton Purchases 225 Shares of Waters Co. (NYSE:WAT)

Bank of Stockton raised its stake in Waters Co. (NYSE:WAT) by 4.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,335 shares of the medical instruments supplier’s stock after acquiring an additional 225 shares during the quarter. Bank of Stockton’s holdings in Waters were worth $1,190,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Invesco Ltd. lifted its holdings in shares of Waters by 20.3% in the second quarter. Invesco Ltd. now owns 775,740 shares of the medical instruments supplier’s stock worth $166,971,000 after acquiring an additional 130,671 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Waters by 252.8% in the second quarter. Mackenzie Financial Corp now owns 638,075 shares of the medical instruments supplier’s stock worth $137,339,000 after acquiring an additional 457,218 shares during the last quarter. Mawer Investment Management Ltd. lifted its holdings in shares of Waters by 7.1% in the second quarter. Mawer Investment Management Ltd. now owns 532,219 shares of the medical instruments supplier’s stock worth $114,531,000 after acquiring an additional 35,506 shares during the last quarter. UBS Asset Management Americas Inc. lifted its holdings in shares of Waters by 2.3% in the second quarter. UBS Asset Management Americas Inc. now owns 472,001 shares of the medical instruments supplier’s stock worth $101,593,000 after acquiring an additional 10,728 shares during the last quarter. Finally, Jensen Investment Management Inc. lifted its holdings in shares of Waters by 1.4% in the second quarter. Jensen Investment Management Inc. now owns 446,637 shares of the medical instruments supplier’s stock worth $96,134,000 after acquiring an additional 5,976 shares during the last quarter. 95.01% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts recently issued reports on the stock. Bank of America lowered shares of Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. ValuEngine lowered shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Barclays lowered shares of Waters from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $210.00 to $195.00 in a report on Wednesday, October 9th. Six analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $208.60.

Shares of NYSE WAT opened at $214.47 on Thursday. The company has a 50 day simple moving average of $220.79 and a 200 day simple moving average of $216.67. The firm has a market cap of $14.63 billion, a PE ratio of 25.87, a price-to-earnings-growth ratio of 2.47 and a beta of 1.07. Waters Co. has a 1 year low of $173.41 and a 1 year high of $255.21. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.65 and a quick ratio of 2.07.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.11 by $0.03. The business had revenue of $599.20 million during the quarter, compared to analyst estimates of $601.46 million. Waters had a net margin of 24.09% and a return on equity of 50.64%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the business earned $1.95 EPS. As a group, research analysts anticipate that Waters Co. will post 9.01 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: Trade War

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.